Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eplerenone for Vascular Function in Type 2 Diabetes
NCT03017703Completed
- Sponsor
- University of Southern Denmark
- Start
- Dec 2016
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of eplerenone in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by University of Southern Denmark. Primary endpoints: Vascular function (Femoral arterial blood flow) at 8 weeks and Insulin sensitivity measured by a insulin clamp at 8 weeks. Started Dec 2016; status: completed.
02
Drugs
eplerenone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03017703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03017703.